← Compound index
COMPOUND RECORD / PCC

PCCПолипептидный комплекс хрящевой ткани

A polypeptide mixture extracted from animal cartilage. The preparation contains the tripeptide Ala–Glu–Asp (AED), which has also been studied separately as synthetic Cartalax.

Recovery
Source linked

What the studies found

Review of earlier studies · 2023

Peptide Regulation of Chondrogenic Stem Cell Differentiation

Study of multiple preparations

Describes the cartilage polypeptide complex PCC and its AED component. The authors reported a Russian Phase II osteoarthritis program in 2023. They connect MSC and fibroblast findings to a cartilage-repair hypothesis.

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology

Study notes · methods, sources and limitations

Participants or model Review of stem-cell differentiation and cartilage research

Important limitations

  • The reported trial concerns PCC, not a trial of isolated Cartalax. Trial identifier, protocol, enrollment and published human outcomes have not been recovered. Phase II is an attributed 2023 statement, not verified current status.

Int J Mol Sci 24(9):8415. PMID 37176122 · Publication record

Original source or citation ↗

Study results and tables ↗

Laboratory analysis · 2020

Identification of short peptides in the composition of polypeptide complexes isolated from animal organs

Study of multiple preparations

EDG and AEDL in the bronchial mucosa complex
EDG 0.028% and AEDL 0.060% of the analyzed extract

Reports KED in vessel complex, AED in cartilage, EDG and AEDL in bronchial mucosa, EDR in brain and KEDW in pancreas. This strengthens sequence-level links in the research program.

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology · Pavlov Institute of Physiology, Russian Academy of Sciences · Institute of Toxicology, Federal Medical-Biological Agency

Study notes · methods, sources and limitations

Participants or model Animal-organ polypeptide complexes analyzed by UHPLC–MS

Design UHPLC–tandem mass spectrometry of six lyophilized animal-tissue complexes, using reference standards for seven target sequences.

Important limitations

  • Molecular detection does not prove identical pharmacology or clinical equivalence. The paper’s discussion of clinical work is not an independent clinical trial.
  • These measurements describe the analyzed preparations. The paper does not characterize all constituents or identify the clinical trial batch.

Uspekhi Sovremennoi Biologii 140(2):140–148 · Publication record

Original source or citation ↗

Study results and tables ↗
01 / OVERVIEW

About PCC

Names in this research collection

Cartilage polypeptide complex · PPC · Cartilage extract

Research background

An animal-cartilage-derived polypeptide complex described in the Russian cartilage research program. It is a mixture containing AED, not a synonym for synthetic Cartalax.

Compound class
Tissue-derived polypeptide complex
Research collection
Peptide bioregulation · editorial grouping
Institutions in linked studies
St. Petersburg Institute of Bioregulation and Gerontology · Pavlov Institute of Physiology, Russian Academy of Sciences · Institute of Toxicology, Federal Medical-Biological Agency
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

Trial program reported in review; primary trial unrecovered

Study methods

Original reports separated from narrative reviews and patents

Independent replication

Independent replication not established by this collection

Source access

Linked abstracts, analytical papers, reviews and patents; individual scope shown below

Safety evidence

Incomplete assessment; findings do not establish safety for personal use

Open a topic for the evidence assessment.

More findings, background and history

What remains unclear

The available experimental studies leave human benefit and safety uncertain.

No human intervention report has been identified among the linked records; unclassified archival leads may remain. Several publications can describe the same participants.

Browse original study records ↗
PEPTIDE RESEARCH / OCT 2026

Related preparations and evidence

Evidence belongs to the preparation actually studied. A tissue extract and a synthetic peptide can belong to the same research tradition without having equivalent effects or safety.

Cartilage & bone: the molecular link

Cartilage polypeptide complex (PCC) → Cartalax / AED

The 2020 UHPLC–MS paper reports AED in cartilage complex. The 2023 review describes PCC as a mixture spanning 75–846 Da.

Clinical evidence and limitations

Cartalax: a published 2015 human dental-surgery study reports better jaw-bone healing; a later research lecture gives 53 patients (28/25). A separate 29-patient knee comparison appears in patent RU2299741C1. PCC Phase II is review-reported and concerns a different preparation.

The PCC trial identifier, formulation, protocol and results remain uncertain. The patent reports symptom changes without a significant radiographic change. Cartilage regeneration remains unestablished.

Related preparations

Some references concern related extracts, reviews or molecular identification rather than direct studies of this compound.

Explore the full bioregulator collection ↗

View this preparation in the Khavinson evidence map ↗

PATENT RESEARCH / COLLECTION UPDATED 7 NOVEMBER 2026

Patents and claimed inventions

These 1 grouped records distinguish claimed molecules, uses, formulations and related chemistry. Patent disclosure does not establish clinical benefit or approval.

2008 · RU2302872C9 · PCC: corrected cartilage-complex publicationManufacturing · Reported in 67.4% of cases

Findings described in words

Pain reduction is reported, but the percentage and patient count do not yield a clear responder denominator.

Pain improvement
Reported in 67.4% of casesAfter a 20-day courseThe text does not explain how this percentage maps to the 15 treated participants
Cartilage-culture findings
Growth-stimulation experiments described in rat cartilage fragmentsLaboratory tissue findings are separate from the patient pain report
All reported results, comparisons and limitations →

Manufacturing. The corrected C9 publication claims a cartilage-derived peptide complex and its production. The related C1 record contains mismatched ovarian claim text.

Use the corrected claim text, not the erroneous C1 text, when tracing the cartilage preparation. A tissue complex is not a single defined peptide.

Publication
RU2302872C9 ↗ · 2008-12-20
Earliest priority / filing
2006-06-22 / 2006-06-22
Original applicant / assignee
Общество С Ограниченной Ответственностью "Сиа Пептайдс"
Indexed status
Not shown; official status unverified · checked 2026-11-06
Patent family
38431016 · family publications are related filings, not independent studies.
Original title, inventors and related publications

Agent normalizing cartilage tissue function and method for its preparing

Inventors: Владимир Хацкелевич Хавинсон (RU); Владимир Хацкелевич Хавинсон; Владимир Викторович Малинин (RU); Владимир Викторович Малинин; Галина Анатольевна Рыжак (RU); Галина Анатольевна Рыжак.

RU2302872C9 · EA010724B1 · RU2302872C1

Original patent PDF ↗

Read source review →

Status is an indexed snapshot, not an official legal assessment. Search the patent collection and read the method →

03 / SOURCE RECORDS

Findings by study

Explore related research ↗

Experiment described in a patent · 2008

PCC: corrected cartilage-complex publication — RU2302872C9

Pain reduction is reported, but the percentage and patient count do not yield a clear responder denominator.

Pain improvement · Reported in 67.4% of cases · The text does not explain how this percentage maps to the 15 treated participants · After a 20-day course

Study notes and original source
2008Patent / reported experimentsFull text available

PCC: corrected cartilage-complex publication — RU2302872C9

Patent-defined substance or composition · Patent publication

Format: Original patent text and indexed metadata · Reviewed: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.

Владимир Хацкелевич Хавинсон (RU), Владимир Хацкелевич Хавинсон, Владимир Викторович Малинин (RU), Владимир Викторович Малинин, Галина Анатольевна Рыжак (RU), Галина Анатольевна Рыжак · RU2302872C9 · patent family 38431016

Pain reduction is reported, but the percentage and patient count do not yield a clear responder denominator.

Results and tables

Reported patent results

Findings described in words

Pain reduction is reported, but the percentage and patient count do not yield a clear responder denominator.

Corrected PCC publication: 33 lumbar-osteochondrosis patients, 15 extract versus 18 saline, alongside complex care.

Population or model Corrected PCC publication: 33 lumbar-osteochondrosis patients, 15 extract versus 18 saline, alongside complex care.

Results · Corrected publication: 33-patient clinical example and cartilage-culture section.
MeasureResultComparison, timing and statistics
Pain improvementReported in 67.4% of casesThe text does not explain how this percentage maps to the 15 treated participants · After a 20-day course
Cartilage-culture findingsGrowth-stimulation experiments described in rat cartilage fragmentsLaboratory tissue findings are separate from the patient pain report

The pain outcome is insufficiently specified and co-treatment complicates attribution. Use the corrected C9 claim text; this cartilage complex is not defined AED Cartalax.

Source for these results ↗ · Reviewed 2026-11-06

Population / setting
Corrected PCC publication: 33 lumbar-osteochondrosis patients, 15 extract versus 18 saline, alongside complex care.
Source reviewed
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Study limitations
  • Use the corrected claim text, not the erroneous C1 text, when tracing the cartilage preparation. A tissue complex is not a single defined peptide.
  • The pain outcome is insufficiently specified and co-treatment complicates attribution. Use the corrected C9 claim text; this cartilage complex is not defined AED Cartalax.
  • Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
  • Status labels are Google Patents index snapshots for the displayed publication or application; each record lists the review date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.

Reviewed 2026-11-06.

Read the source ↗

Review of earlier studies · 2023

Peptide Regulation of Chondrogenic Stem Cell Differentiation

Describes the cartilage polypeptide complex PCC and its AED component. The authors reported a Russian Phase II osteoarthritis program in 2023. They connect MSC and fibroblast findings to a cartilage-repair hypothesis.

Study notes and original source
2023ReviewFull text available

Peptide Regulation of Chondrogenic Stem Cell Differentiation

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology

Linkova N, Khavinson V, Diatlova A, Myakisheva S, Ryzhak G · Int J Mol Sci 24(9):8415. PMID 37176122

Describes the cartilage polypeptide complex PCC and its AED component. The authors reported a Russian Phase II osteoarthritis program in 2023. They connect MSC and fibroblast findings to a cartilage-repair hypothesis.

Population / setting
Review of stem-cell differentiation and cartilage research
Source reviewed
Full-text XML checked, including PCC/AED discussion and references 7, 9, 68–70. Trial documents were not supplied by this review.
Study limitations
  • The reported trial concerns PCC, not a trial of isolated Cartalax.
  • Trial identifier, protocol, enrollment and published human outcomes have not been recovered. Phase II is an attributed 2023 statement, not verified current status.

Reviewed 2026-09-29.

Read the source ↗

Laboratory analysis · 2020

Identification of short peptides in the composition of polypeptide complexes isolated from animal organs

Reports KED in vessel complex, AED in cartilage, EDG and AEDL in bronchial mucosa, EDR in brain and KEDW in pancreas. This strengthens sequence-level links in the research program.

Study notes and original source
2020Analytical / composition studyFull text available

Identification of short peptides in the composition of polypeptide complexes isolated from animal organs

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology · Pavlov Institute of Physiology, Russian Academy of Sciences · Institute of Toxicology, Federal Medical-Biological Agency

I. K. Zhurkovich, N. G. Kovrov, G. A. Ryzhak, E. S. Mironova, V. Kh. Khavinson · Uspekhi Sovremennoi Biologii 140(2):140–148

Reports KED in vessel complex, AED in cartilage, EDG and AEDL in bronchial mucosa, EDR in brain and KEDW in pancreas. This strengthens sequence-level links in the research program.

Results and tables

Reported findings and study design

UHPLC–tandem mass spectrometry of six lyophilized animal-tissue complexes, using reference standards for seven target sequences.

Population or model Animal-organ polypeptide complexes analyzed by UHPLC–MS

Results · Original analytical paper, Table 3 and chromatograms.
MeasureResultComparison, timing and statistics
EDG and AEDL in the bronchial mucosa complexEDG 0.028% and AEDL 0.060% of the analyzed extract
Identified short peptides by extract
Identified short peptides by extract
ExtractSequenceReported proportion
Bronchial mucosaEDG0.028%
Bronchial mucosaAEDL0.060%
VesselsKED0.020%
CartilageAED0.020%
BrainEDR0.024%
PancreasKEDW0.035%

These measurements describe the analyzed preparations. The paper does not characterize all constituents or identify the clinical trial batch.

Source for these results ↗ · Reviewed 2026-11-15

Population / setting
Animal-organ polypeptide complexes analyzed by UHPLC–MS
Source reviewed
Original analytical paper, test method, Table 3 and chromatograms in Figures 1–6.
Study limitations
  • Molecular detection does not prove identical pharmacology or clinical equivalence.
  • The paper’s discussion of clinical work is not an independent clinical trial.

Reviewed 2026-11-15.

Read the source ↗

Follow shared publications or research classes. These links do not establish equivalent effects between compounds.

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗